by John Riehl
Iowa City IA (SPX) Sep 20, 2012
University of Iowa researchers have determined that thigh size in obese people is a reason their hip implants are more likely to fail. In a study, the team simulated hip dislocations as they occur in humans and determined that increased thigh girth creates hip instability in morbidly obese patients (those with a body mass index (BMI) greater than 40).
The researchers propose that surgeons modify surgical procedures to minimize the chance of dislocation in obese patients and consider other designs for hip replacement implants.
"We have shown that morbidly obese patients' thighs are so large that they are actually pushing each other outward and forcing the implant out of its socket," says Jacob Elkins, a UI graduate student and first author of the paper published in the journal Clinical Orthopaedics and Related Research.
"Studies have shown up to a 6.9-fold higher dislocation rate for morbidly obese patients compared to normal weight patients.
Total hip replacement gives mobility back to people who experience debilitating hip joint pain. According to the National Institute of Arthritis and Musculoskeletal and Skin Disease (NIAMS), 231,000 total hip replacements are performed annually in the U.S. and more than 90 percent of these do not require follow-up repair or replacement.
But when an implant fails, it is painful, and costly. Studies have shown that dislocation ranks as the most common reason for failed implants, according to Medicare hospital discharge data.
A hip implant is a ball-in-socket mechanism, designed to simulate a human hip joint. However, it lacks the connective tissue that stabilizes a normal hip joint, meaning the ball portion of the implant can sometimes "pop out."
Clinical studies point to an increased dislocation risk among obese patients with total hip replacements, but the reasons have remained unclear.
Dislocation requires extreme range of motion, such as flexing at the waist. Given the reduced range of motion in the obese, why do they experience more dislocations?
Engineering a better hip implant
With the ability to simulate movements in human bodies of varying sizes, the team could test different implants. They also looked at the various implants' performances in different body types. They used a hip-center-to-hip-center distance of 200 millimeters as a basis for their analyses of thigh girth for eight different BMIs, ranging from 20 to 55.
The research team ran computations to examine the joint stability of several different hip implants. They tested two femoral head sizes (28 and 36 millimeters), normal versus high-offset femoral neck, and multiple cup abduction angles.
The researchers report three main findings: 1) thigh soft tissue impingement increased the risk of dislocation for BMIs of 40 or greater; 2) implants with a larger femoral head diameter did not substantially improve joint stability; 3) using an implant with a high-offset femoral stem decreased the dislocation risk.
"The larger your legs are, the more force that goes through the hip joint," Elkins says. "It's a simple concept. When your thighs are real big, they push on the hips."
Recommendations for surgeons
"The number one thing surgeons can do is what is called a 'high offset femoral stem,'" says senior author Thomas Brown, UI professor of orthopaedic surgery, referring to the portion of the implant that attaches to the patient's upper thigh bone, or femur.
"Basically, the implant's femoral stem is longer, so it effectively shifts the leg further away from the center rotation of the joint. The thighs then would need to move even further inward before they would abut one another and generate the forces necessary for dislocation."
The study, titled "Morbid obesity may increase dislocation in total hip patients: A biomechanical analysis," was published online on Aug. 21. Elkins is in the UI's College of Engineering Biomechanical Engineering Program and the Carver College of Medicine's Medical Scientist Training Program. Other authors are Matej Daniel, assistant professor at Czech Technical University in Prague, Czech Republic, and former Fulbright Research Scholar at UI Hospitals and Clinics; Douglas Pedersen, UI research associate professor of orthopaedic surgery; Bhupinder Singh, UI doctoral candidate in physical therapy; John Yack, UI associate professor of physical therapy; and John Callaghan, UI professor of orthopaedic surgery.
University of Iowa
Hospital and Medical News at InternDaily.com
Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.
Body heat, fermentation drive new drug-delivery 'micropump'
West Lafayette IN (SPX) Sep 14, 2012
Researchers have created a new type of miniature pump activated by body heat that could be used in drug-delivery patches powered by fermentation. The micropump contains Baker's yeast and sugar in a small chamber. When water is added and the patch is placed on the skin, the body heat and the added water causes the yeast and sugar to ferment, generating a small amount of carbon dioxide gas. ... read more
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2012 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement|